Status: In close down
Condition:
Neovascular Age-related Macular Degeneration
Official Title:
A Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Patients With Neovascular Age-Related Macular Degeneration.
[INSERT A BRIEF SUMMARY]
Drug: FaricimabOther: Sham Procedure
No active trials.